| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 27 |
| 1 | PREDNISONE | 25 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 3 | TACROLIMUS OINTMENT 0.1% | 25 |
| 4 | MYCOPHENOLATE MOFETIL | 24 |
| 5 | METHOTREXATE SODIUM | 20 |
| 6 | METHOTREXATE | 18 |
| 7 | PREDNISOLONE | 17 |
| 8 | PREDNISOLONE ORAL | 17 |
| 9 | PREDNISOLONE ORAL SOLUTION | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | WHITE PETROLEUM | 1 | 0.0192 |
| 1 | ANORECTAL OINTMENT | 4 | 0.0183 |
| 2 | DIMETHYL SULFOXIDE | 1 | 0.0041 |
| 3 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0030 |
| 4 | ACAMPROSATE CALCIUM | 1 | 0.0030 |
| 5 | BORIC ACID | 1 | 0.0028 |
| 6 | MITOMYCIN | 9 | 0.0025 |
| 7 | BUPRENORPHINE HCL | 2 | 0.0023 |
| 8 | EPHEDRINE HYDROCHLORIDE | 1 | 0.0022 |
| 9 | IDARUBICIN HYDROCHLORIDE | 2 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimalarial [EPC] | 11 | 0.0011 |
| 1 | Antiprotozoal [EPC] | 11 | 0.0010 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 12 | 0.0005 |
| 3 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 5 | Bile Acid [EPC] | 4 | 0.0002 |
| 6 | Aluminum Complex [EPC] | 3 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 4 | 0.0001 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 9 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |